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Diagnostic evaluation of risk for bleeding in cardiac surgery with 
extracorporeal circulation*
Objective: to identify the risk factors associated with cases of excessive bleeding in patients 
submitted to cardiac surgery with extracorporeal circulation. Method: case-control study on 
the factors of risk for bleeding based on the analysis of data from the medical charts of 216 
patients submitted to cardiac surgery with elective extracorporeal circulation during a three-year 
period. Results: variables that are commonly associated with excessive bleeding in studies in the 
field were analyzed, and the following were considered as risk factors for the nursing diagnosis 
“risk for bleeding” (00206) in cardiac surgery with extracorporeal circulation: Body mass index 
lower than 26.35kg/m² (Odds ratio = 3.64); Extracorporeal circulation longer than 90 minutes 
(Odds ratio = 3.57); Hypothermia lower than 32°C (Odds ratio = 2.86); Metabolic acidosis 
(Odds ratio = 3.50) and Activated partial thromboplastin time longer than 40 seconds (Odds 
ratio = 2.55). Conclusion: such variables may be clinical indicators of an operational nature for 
a better characterization of the risk factor “treatment regimen” and a refinement of knowledge 
related to coagulopathy induced by extracorporeal circulation, which is currently presumably 
incorporated into the “treatment regimen” category of the nursing diagnostic classification by 
NANDA International, Inc.
Descriptors: Thoracic Surgery; Extracorporeal Circulation; Risk Factors; Nursing Diagnosis; 
Hemorrhage; Postoperative Care.
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Introduction
Bleeding is a common and severe occurrence in the 
postoperative period of cardiac surgeries. Excessive losses 
tend to require corrective measures, such as transfusions, 
thus leading to complications, as for instance: surgical 
reexploration, increased mortality after 30 days, and 
prolongation of mechanical ventilation for more than 
24 hours(1-3). Hence, in recent years, there has been 
investment in the creation and use of more appropriate 
protocols to improve hemostasis(4). The literature has 
presented bleeding risk factors or elements that indicate 
the need for transfusion in cardiac surgery, among 
them: the use and the discontinuation time of the use 
of antithrombotic agents before surgery, replacements 
with colloidal solutions, techniques and equipment for 
extracorporeal circulation (ECC), comorbidities, clinical 
conditions, such as coagulopathies and hemoglobinopathies 
and chronic diseases, such as high blood pressure, renal 
failure and diabetes, among other factors(4-6).
Despite the advances made by studies on the 
factors of risk for bleeding in adults undergoing cardiac 
surgery with ECC, there are still several areas of 
uncertainty and topics for additional studies(7), which 
can be partly explained by the patients’ preoperative 
clinical conditions and the multiplicity of therapeutic 
interventions that demarcate the perioperative situation, 
as well as the complexity involved in cardiac surgeries 
and the difficulty in studying their variables separately.
The relevance of bleeding as a professional focus of 
nursing is recognized in the NANDA International, Inc. 
taxonomy by the incorporation of the nursing diagnosis 
(00206) “risk for bleeding” defined as the “vulnerability 
to reduction in blood volume that may compromise 
an individual’s health”(8). Among the factors of risk 
for bleeding presented in the nursing diagnosis is the 
inclusion of the generic concept of “treatment regimen”, 
which could embrace elements related to cardiac surgery 
conditions. However, for the nurse operating in the 
perioperative period of cardiac surgery, the concept of 
treatment regimen requires detailed information on what 
would be the significant operational elements related to 
bleeding in the postoperative period of cardiac surgeries.
A study published by nurse researchers 
demonstrated the factors associated with excessive 
bleeding after cardiac surgery, thus identifying significant 
factors related to excessive bleeding and advancing the 
knowledge on the subject. The authors, however, did not 
explicitly correlate the results to the nursing diagnosis 
risk for bleeding(9). Nevertheless, despite the evidence 
already obtained, some variables have different values 
of relevance in the estimation of risk for bleeding, 
and different criteria are adopted for the definition of 
excessive bleeding(2,6,10-12). Therefore, it is understood that 
further studies are required in order to base an accurate 
diagnosis by nurses so as to provide valid operational 
criteria.
In view of the above, this article aims to identify the 
risk factors associated with cases of excessive bleeding 
in patients submitted cardiac surgery with ECC.
Method
This is a case-control study on the factors of risk for 
bleeding conducted at a general federal tertiary military 
hospital located in the city of Rio de Janeiro, southeastern 
Brazil. Patients undergoing elective cardiac surgery with 
ECC were investigated. The study was approved by the 
Research Ethics Committee under registration number 
55217516.2.0000.5238.
Variables potentially associated with postoperative 
bleeding were selected from the taxonomy of NANDA 
International, Inc.(8) and from a literature review. 
Variables mainly found in studies whose characteristics 
converged to those of the clientele and institution 
investigated were preferentially selected(3-6,10).
The preoperative variables selected for the study as 
risk factors are presented in Figure 1.
The intraoperative variables selected for the study 
as risk factors are presented in Figure 2.
The postoperative variables selected for the study 
as risk factors are presented in Figure 3.
Studies and clinical practice have adopted different 
definitions and criteria to define abnormal perioperative 
bleeding, such as drainage through the thoracic tubes, 
magnitude of blood transfusions, delayed sternal closure, 
and use of coagulation concentrates(2). The present study 
adopted the concept of excessive bleeding as a function 
of the volume drained by the thoracic tubes because it 
is aligned with a nursing intervention and more easily 
articulated to the nursing diagnosis. The following were 
adopted as criteria for excessive bleeding: bleeding from 
mediastinal and/or pleural tubes with values equal to or 
greater than 1.5ml drainage/kg/h for at least 3 hours(11), 
or drainage greater than 200ml/h or fraction of an hour 
or greater than 2ml/kg/hour for two consecutive hours 
in the first 6 hours postoperatively(3). Blood loss was 
accompanied by hourly measurements of mediastinal 
and/or pleural drainage during the first 24 hours, with 
values verified and documented by the nursing team.
Data were collected by one of the researchers 
throughout 2016 from the medical charts of all 
individuals undergoing cardiac surgeries at the institution 
between 2013 and 2015. The time interval is due to 
the full implantation of electronic medical charts in the 
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Variable Operational definitions and criteria of risk for excessive bleeding
Diagnosed high blood pressure Verified as a clinical diagnosis existing prior to surgery according to the previous pathological history 
recorded in the electronic medical chart. Risk for bleeding: occurrence.
Prolonged PAT* Obtained from the last laboratory test collected up to one week prior to surgery. Source: electronic medical 
chart. Risk for bleeding: longer than 14 seconds.
Prolonged PTTa† Obtained from the last laboratory test collected up to one week prior to surgery. Source: electronic medical 
chart. Risk for bleeding: longer than 40 seconds.
Decreased hematocrit levels
Obtained from the last laboratory test collected up to one week prior to surgery. Source: electronic medical 
chart. Risk for bleeding: lower than 30%‡.
Decreased platelet count
Obtained from the last laboratory test collected up to one week prior to surgery. Source: electronic medical 
chart. Risk for bleeding: fewer than 150,000 cells/mm³§.
Antiplatelet therapy (discontinuation)
Verified in medicine prescriptions prior to surgery, collected from physical chart. Risk for bleeding: no 
discontinuation or discontinuation for less than 5 days from surgery.
BMI||
Calculated based on the weight and height recorded in electronic medical chart in a previous evaluation to 
the surgery. The lowest risk for excessive bleeding for overweight and obesity was considered(13-15). Risk for 
bleeding(9): lower than 26.35kg/m²¶.
*Prothrombin activation time; †Activated partial thromboplastin time; ‡Percentage; §Cubic millimeters; ||Body mass index; ¶Kilos per square meter
Figure 1 – Preoperative variables selected to be tested as risk factors for bleeding. Rio de Janeiro, RJ, Brazil, 2013-2015
Variable Operational definitions and criteria of risk for excessive bleeding
ECC time*
Obtained from the perfusion form filled out by the perfusion professional in the intraoperative period. Risk 
for bleeding: prolonged ECC*, of approximately 90-110 minutes(16-18).
Surgery time
Obtained from the intraoperative control form filled out by the nursing technician circulating in the room, 
which shows the time of surgery. Risk for bleeding: time longer than the average time of 300 minutes for 
cardiac surgery(19).
Minimum esophageal temperature 
(reduced)
Collected from the perfusion form filled out by the perfusion professional. Esophageal temperature 
reached during ECC* time. Risk for bleeding: lower than 32°C†(20-21).
Heparin reinforcement in ECC*
Obtained from the perfusion form filled out by the perfusion professional. Risk for bleeding: an additional 
dose of heparin (5000IU‡), from 1ml§, administered by the perfusion professional into the ECC* circuit 
when evaluating the ACT|| test.
Additional hydric volume in ECC*
Obtained from the perfusion form filled out by the perfusion professional. Risk for bleeding: additional 
volume of crystalloid solution (Ringer Lactate) administered by the perfusion professional in the ECC* 
circuit.
Protamine reinforcement after ECC*
Obtained from the infusion form filled out by the perfusion professional. Risk for bleeding: additional 
dose of protamine (from 50mg¶) administered after evaluation of the ACT|| test for reversing the effect of 
systemic anticoagulation by heparin.
*Extracorporeal circulation; †Degrees Celsius; ‡International units; §Milliliters, ||Activated coagulation time; ¶Milligrams
Figure 2 – Intraoperative variables selected to be tested as risk factors for bleeding. Rio de Janeiro, RJ, Brazil, 2013-2015
Variable Operational definitions and criteria of risk for excessive bleeding
High blood pressure of difficult 
control
Considered from the need to administer two or more vasoactive drugs for pressure control. Source: 
patient’s medicine prescription in the immediate postoperative period. Risk of bleeding: occurrence.
Postoperative metabolic acidosis
Interpreted based on pH* and other gasometric data of the arterial blood collected immediately upon 
the patient’s arrival at the postoperative unit. Obtained from the time control form for vital parameters 
completed by the nursing professional. Risk for bleeding: occurrence.
Decreased hematocrit levels
Obtained from the first laboratory test performed within 30 minutes after the patient’s arrival at the 
postoperative unit. Source: electronic medical chart. Risk for bleeding: lower than 30%†.
Decreased platelet count
Obtained from the first laboratory test performed within 30 minutes after the patient’s arrival at the 
postoperative unit. Source: electronic medical chart. Risk for bleeding: fewer than 150,000 cells/mm³‡.
Prolonged PAT§ Obtained from the first laboratory test performed within 30 minutes after the patient’s arrival at the 
postoperative unit. Source: electronic medical chart. Risk for bleeding: longer than 14 seconds.
Prolonged PTTa|| Obtained from the first laboratory examination performed within 30 minutes after the patient’s arrival at the 
postoperative unit. Source: electronic chart. Risk for bleeding: longer than 40 seconds.
*Hydrogen potential; †Percentage; ‡Cubic millimeters; §Prothrombin activation time; ||Activated partial thromboplastin time
Figure 3 – Postoperative variables selected to be tested as risk factors for bleeding. Rio de Janeiro, RJ, Brazil, 2013-
2015
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institution in order to facilitate information retrieval, the 
quality and truthfulness of the data collected.
The collected data were recorded in a 
collection instrument created with the purpose of 
characterizing the profile of the population submitted 
to cardiac surgery at the said hospital, in addition to 
characterizing the variables that occur at the different 
perioperative moments of cardiac surgery. To that 
end, this instrument contained information on the 
population’s profile as well as their clinical, surgical 
and postoperative data. The possibility of occurrence of 
information bias due to errors in recording data in the 
medical charts was considered. However, it should be 
noted that some conditions of data production probably 
minimized such risk, among them: the qualification 
and technical preparation of the team responsible for 
the documentation and the exclusive allocation of a 
nurse and a physician for the care provided during 
the immediate postoperative phase, including record 
making and the use of a standardized device for 
accurate blood drainage measurement.
The medical charts of patients who had undergone 
elective cardiac surgery with ECC available for 
consultation at Seção Arquivo Médico* (SAM) of the 
institution during the data collection period were eligible. 
Medical charts with incomplete records were excluded 
from the study.
Of a total of 275 cardiac surgeries performed 
between 2013 and 2015, 269 were elective with ECC, 
thus constituting the potentially eligible sample. Fourteen 
medical charts with incomplete information and 22 that 
were not available for consultation were discarded. There 
were three death losses during the perioperative period; 
therefore, 230 charts remained.
Based on the excessive-bleeding criteria, the 
occurrence of 24 cases was observed, and the case/
control ratio was established as 1 case to 8 controls, so 
as to maximize the statistical power of the study in view 
of the available sample(22-23). One hundred and ninety-
two medical charts were drawn as control.
The chi-square tests or Fisher’s test were used to 
test the differences between the proportions obtained for 
the groups of cases and controls. In order to evaluate 
the risk of the variables for bleeding, the odds ratios 
(OR) and the 95% confidence intervals were calculated. 
The variables that obtained an odds ratio above 1.0 
with p < 0.05 were considered as risk factors with 
* Medical Records Departaments
statistical significance. The data were analyzed by the 
MedCalceasy-to-use statistical software®.
Results
The 216 participants were mostly elderly men, which 
is in agreement with the characteristics observed in similar 
studies(1,3,5,9,12-13,18). Regarding the surgery performed, 
there was a predominance of revascularization surgeries, 
with 50% among cases and 70.83% among controls, 
followed by valve replacement (29.17% for cases and 
27% for controls), combined surgeries (20.83% for cases 
and 14.06% for controls), atrial septal defect correction, 
myxoma resection and Bentall-De Bono surgery, thus 
comprising the remaining 3.13% of controls. The 
comorbidities observed were: diabetes mellitus (37.5% of 
cases and 62% of controls), chronic renal failure (4.2% of 
cases and 3.5% of controls) and coagulopathies in 1.04% 
and hemoglobinopathies in 0.52% of controls. None of 
the characterization data contributed to the chance of 
excessive bleeding in the sample.
Table 1 shows the occurrence data for the 
excessive-bleeding risk variables as a function of the 
condition, such as case-group and control-group.
Among the categorical variables, “return to 
the operating room” showed a higher proportion of 
occurrences in the case-group as compared to the 
control-group with statistical significance. Regarding 
the numerical variables, the differences between the 
means with statistical significance, indicating a greater 
association with risk for excessive bleeding in the 
case-group were: weight, Bodly Mass Index (BMI), 
reduced minimum esophageal temperature and heparin 
reinforcement, with values indicating risk for the case-
group. Preoperative hemoglobin showed a lower mean in 
the control-group, together with statistical significance.
Table 2 shows the odds ratio for the variables to 
represent a risk factor for excessive bleeding in the 
postoperative period of cardiac surgery with ECC. 
For this purpose, the absolute and percent frequency 
values, odds ratio, confidence interval and p-value of the 
analyzed variables are indicated.
The variables that, due to their increased odds ra-
tio, can be considered as risk factors in the preoperative 
period are: BMI lower than 26.35kg/m² (OR = 3.64); in 
the intraoperative period: ECC longer than 90 minutes 
(OR = 3.57); Esophageal temperature lower than 32°C 
(OR = 2.86); in the postoperative period: Metabolic 
acidosis (OR = 3.50); Activated partial thromboplastin 
time longer than 40 seconds (OR = 2.55).
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Table 1 – Variables associated with the group with excessive bleeding (cases) and without excessive bleeding 
(controls). Rio de Janeiro, RJ, Brazil, 2013-2015
Variables
Cases Controls p value*
n = 24 n = 192
Categorical n % N % p†
Male 18 64.60 135 69.40 0.8125
Female 6 35.40 57 30.60 0.6344
Systemic high blood pressure 20 83.30 170 88.50 0.4627
Additional hydric volume in ECC‡ 14 58.30 104 54.10 0.6975
Return to the operating room 7 29.17 0 0 < 0.0001§
Post-ECC‡ platelet transfusion 2 8.33 20 10.9 0.7513
Numerical mean (standard deviation) mean (standard deviation) p||
Preoperative period
Age (years) 66.88 (8.64) 65.89 (10.84) 0.5316
Weight (kg¶) 66.66 (9.05) 75.21 (14.33) 0.0005§
Body mass index (kg/m2**) 24.35 (2.54) 27.21 (4.49) 0.0031†
Hematocrit (%††) 41.25 (4.44) 39.19 (5.42) 0.0663
Platelet count (cell/mm3‡‡) 212125 (60.57) 226890 (65.50) 0.1924
Hemoglobin (mg/dl§§) 13.98 (1.46) 13.19 (1.98) 0.0370§
Prothrombin activation time (seconds) 13.57 (0.65) 14.05 (3.28) 0.7247
Activated partial thromboplastin time 38.38 (5.72) 38.84 (9.68) 0.3782
Intraoperative period
Reduced minimum esophageal temperature (°C||||) 30.57 (2.90) 32.06 (1.37) 0.0121§
Heparin reinforcement (IU¶¶) 5291.71 (62.82) 2591.15 (43.82) 0.0066†
Protamine reinforcement (mg***) 18.75 (35.55) 28.13 (39.90) 0.2730
Surgery time (minutes) 304.88 (75.74) 318.75 (96.12) 0.2891
ECC‡ time (minutes) 112.25 (31.45) 99.14 (31.53) 0.1296
Postoperative period
Hematocrit (%††) 34.26 (4.40) 35.43 (4.33) 0.2135
Platelets (cells/mm3‡‡) 165.160 (52.18) 179.080 (53.96) 0.2333
Hemoglobin (mg/dl§§) 11.75 (1.62) 11.99 (1.52) 0.9626
Prothrombin activation time (seconds) 16.11 (1.40) 15.89 (1.92) 0.5774
Activated partial thromboplastin time 41.87 (7.33) 38.03 (6.35) 0.0019§
*p value; †Significance test referring to Fisher’s Test; ‡Extracorporeal circulation; §Statistical significance; ||Significance test referring to the Paired t-test; 
¶Kilos; **Kilos per square meter; ††Percentage; ‡‡Cubic millimeters; §§Milligrams per deciliter; ||||Celsius; ¶¶International units; ***Milligrams
Table 2 – Analysis of the association between the risk factor and bleeding, expressed by the Odds ratio. Rio de Janeiro, 
RJ, Brazil, 2013-2015
Risk factors
Cases Controls Odds ratio and significance
N n OR* CI† 95% p value‡
Preoperative period
Diagnosed systemic high blood pressure 20 170 0.64 (0.20 to 2.06) 0.4627
Platelet antiaggregation < 5 days 22 62 0.90 (0.35 to 2.29) 0.8353
Prothrombin activation time > 14 seconds 16 38 0.75 (0.28 to 1.98) 0.5650
Activated partial thromboplastin time > 40 seconds 13 38 1.24 (0.50 to 3.07) 0.6343
Hematocrit > 30%§ 0 10 0.35 (0.02 to 6.24) 0.4788
Platelets < 150,000 cells/mm3|| 6 18 1.72 (0.53 to 5.53) 0.3633
Body mass index < 26.35kg/m²¶ 19 98 3.64 (1.31 to 10.15) 0.0134**
Intraoperative period
ECC†† > 90 minutes 46 121 3.57 (1.17 to 10.85) 0.0247**
Surgery > 300 minutes 27 72 1.15 (0.49 to 2.71) 0.7364
Esophageal temperature < 32°C‡‡ 34 55 2.86 (1.16 to 7.00) 0.0215**
Additional hydric volume in ECC†† 29 78 1.18 (0.50 to 2.79) 0.6993
Heparin reinforcement in ECC†† 25 54 2.28 (0.96 to 5.40) 0.0607
Postoperative period
High blood pressure of difficult control 17 45 0.73 (0.23 to 2.27) 0.5951
Metabolic acidosis 18 58 3.50 (1.35 to 9.05) 0.0098**
Hematocrit < 30%§ 8 14 2.39 (0.80 to 7.14) 0.1172
Platelets < 150,000 cells/mm3|| 19 42 1.90 (0.80 to 4.50) 0.1409
Activated partial thromboplastin time > 40 seconds 21 39 2.55 (1.08 to 6.03) 0.0324**
Prothrombin activation time > 14 seconds 44 124 1.57 (0.34 to 7.10) 0.5573
*Odds ratio; †95% confidence interval; ‡p value; §Percentage; ||Cubic millimeters; ¶Kilos per square meter; **Statistical significance; ††Extracorporeal 
circulation; ‡‡Degrees Celsius
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Discussion
The study found variables that were associated 
with excessive bleeding after cardiac surgery with ECC 
in the preoperative and intraoperative periods and in the 
first postoperative minutes. BMI lower than 26.35kg/
m2, ECC time longer than 90 minutes, esophageal 
temperature lower than 32°C, and metabolic acidosis 
and activated partial thromboplastin time longer than 
40s were validated factors and that have already been 
identified in other studies(2-4,6,9,12,24). On the other hand, 
there were variables that did not reach statistical 
significance values in the present study, but were 
considered to be associated with excessive bleeding in 
the abovementioned investigations.
The lack of agreement among the findings about 
the factors of risk for bleeding points to the importance 
of research on the subject as much as it raises questions 
about the standardization of criteria linked to the risk 
for bleeding in patients undergoing cardiac surgeries. 
The standardization of defining criteria for abnormal 
or excessive bleeding is one of the aspects that points 
to a careful interpretation of the data in studies on 
excessive bleeding. For example, the criteria used in 
studies include various operational strategies, such 
as monitoring drainage through thoracic tubes using 
standard values in ml/h or ml/kg/h or associated with 
other indicators, such as follow-up on delayed sternal 
closure and evaluation of the use of transfusions(2-3,9).
The results obtained in the present study were 
encouraging in relation to the criterion adopted to define 
excessive bleeding, especially because it was observed 
that all the patients who needed surgical reexploration 
were in the case-group. In a way, this shows a 
practical value of the criterion selected to establish the 
phenomenon of excessive bleeding.
Regarding BMI values, the studies present different 
cut-off points to establish the value that defines the 
excessive-bleeding condition in the postoperative 
period or with hemorrhagic complications, such as for 
example: lower than 20kg/m2(24), lower than or equal 
to 24kg/m2(15), 25±3kg/m2(12) and lower than 26.35kg/
m2(9). We chose to use the value lower than 26.35 
kg/ m2 as a characterization of the risk factor when 
considering the means for the case- and control-groups. 
Once the variable in question was tested, an increased 
odds ratio was obtained with statistical significance, 
which was essential to consider it a diagnostic risk 
factor. Despite the differences among the BMI values 
that would be related to excessive bleeding, there is 
something in common among the studies, namely: the 
predictive character that low weight increases the risk 
for bleeding. Using the results of the abovementioned 
studies, an assumption is made that patients submitted 
to ECC are more susceptible to the effects of changing 
coagulation factors during hemodilution(6). Consideration 
should be given to the possible risks of associating low 
BMI with high crystalloid infusion, as an example, of the 
implications for the professionals involved, including 
perfusion professionals.
The relationships in the increased postoperative 
bleeding attributed to risk factors of low esophageal 
temperature, metabolic acidosis and changes in activated 
partial thromboplastin time are undesired consequences 
of extracorporeal circulation(6). ECC produces a set 
of responses related to the interaction involving 
inflammatory reactions, fibrinolysis and coagulation, and 
hemodilution and increased consumption of coagulation 
factors due to increased fibrinolysis may be the cause of 
ECC-induced coagulopathy(25).
Metabolic acidosis and hypothermia induced by 
ECC contribute to exacerbate changes in the coagulation 
chain(25). Such alterations associated with the other risk 
factors probably close a multifactor mechanism that 
culminates in the increased mean of activated partial 
thromboplastin time (PTTa), which was observed in 
the postoperative period of patients in the case-group. 
PTTa is one of the laboratory tests that comprise the 
evaluation standard for management of post-ECC 
coagulopathy(26) and, in light of the results, it becomes 
a clinical risk-factor indicator to be evaluated for the 
definition of the nursing diagnosis risk for bleeding in 
the postoperative period.
The heparin reinforcement administered, on 
average, at a larger dose to the case-group when 
compared to the control-group (Table 1) may be 
related to excessive bleeding. This hypothesis gains 
strength when we consider that a longer ECC time also 
increases the need for heparin administration (heparin 
reinforcement)(6).
It is understood that the study brings relevant 
contributions to the refinement of nursing diagnosis 
risk for bleeding, as it allows for the application of the 
concept in the field of cardiac surgery by providing 
operational elements for the best use of risk factor 
“treatment regimen” and clinical adequacy of ECC-
induced coagulopathy as a substitute for risk factor 
“inherent coagulopathy”(8). Coagulopathy is due to 
coagulation disorders that include complications related 
to trauma or are inherent to the patient, such as 
thrombocytopenia, for example(8,27), and it cannot be 
considered to be in the same class as the coagulopathies 
related to extracorporeal circulation. Additionally, there 
is, according to the classification by the Diagnosis 
Development Committee (DDC), the potential 
contribution from the identification of risk factors by 
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means of clinical studies (validation and testing), level 
3 of evidence(8).
For the nursing diagnostic evaluation, the study 
supports the relevance of measurement or monitoring 
actions that can be performed by the nursing team, 
which contributes to increase the nurse’s diagnostic 
accuracy in the early detection of risk for bleeding in the 
immediate postoperative period as well as to promote 
the perception of the importance of the nursing 
diagnosis in collaborating with useful information to 
the practice of physicians and other members of the 
health care team. For nurses working in cardiology 
units, the study provides clinical information that can 
base a better selection of nursing interventions and 
more effective decision making in the monitoring of 
excessive-bleeding signs.
The corroboration of the findings in the present 
study by other investigations conducted by nurses and 
physicians tend to broaden the interest potential of the 
topic to action based on possibilities of multidisciplinary 
research collaboration, with gains for the advancement 
of knowledge in the area.
It is understood that the main limitation of the 
study was related to its retrospective nature, especially 
regarding the potential bias of information inaccuracy. 
However, the low occurrence of bleeding at the 
institution chosen for the study was one of the criteria 
that motivated the choice of the case-control research 
design. The authors assume that the data production 
conditions, already presented in the method section, 
may have minimized such methodological limit, which 
is difficult to overcome in the type of study developed.
Conclusion
Considering the findings in the present study, it was 
concluded that the variables associated with excessive 
bleeding after cardiac surgery with extracorporeal 
circulation were: BMI lower than 26.35kg/m2, ECC time 
longer than 90 minutes, esophageal temperature lower 
than 32°C and metabolic acidosis and activated partial 
thromboplastin time longer than 40s. Such variables 
can be considered as clinical indicators that would best 
characterize risk factor “treatment regimen” of the 
diagnostic classification by NANDA International, Inc. 
for the clientele studied. In addition, it would support 
the delimitation of elements for operational definitions 
related to ECC-induced coagulopathy, considering that 
the nursing diagnosis risk factor “inherent coagulopathy” 
does not adequately apply to most cases of excessive 
bleeding in the postoperative period of cardiac surgery.
The study on the factors of risk for bleeding in 
cardiac surgery provides relevant information for the 
validation of the nursing diagnosis and application in the 
care for people undergoing cardiac surgeries.
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